Cochlear Limited (ASX:COH) just released its interim report and things are looking bullish. It was overall a positive result, with revenues beating expectations by 6.8% to hit AU$743m. Cochlear also ...

Cochlear (ASX:COH) has had a great run on the share market with its stock up by a significant 9.3% over the last week. Given that stock prices are usually aligned with a company's financial ...

I think some shares stand out as great long term holds. The post The ASX 200 stocks I'd be happy to hold until retirement ...

Cochlear Limited, which creates implantable hearing devices, has taken a technological leap forward with a device that syncs up with various Apple products. The Nucleus 7 Sound Processor, which was ...

Want to participate in a short research study? Help shape the future of investing tools and receive a $60 prize! Today we are going to look at Cochlear Limited (ASX:COH) to see whether it might be an ...

Cochlear Limited (ASX:COH) last week reported its latest half-yearly results, which makes it a good time for investors to dive in and see if the business is performing in line with expectations.

In a report released today, Sean Laaman from Morgan Stanley maintained a Hold rating on Cochlear Limited (CHEOF – Research Report), with a price target of A$240.00. The company’s shares closed ...

Cochlear Limited, a medical device company specializing in implantable hearing solutions, is launching two new bone conduction sound processor devices for patients with high levels of hearing loss.

One of the best investments we can make is in our own knowledge and skill set. With that in mind, this article will work through how we can use Return On Equity (ROE) to better understand a business.

Cochlear Limited (AU:COH) has released an update. Cochlear Limited recently reported changes in the interests of its director, Diggory William Howitt, involving the acquisition of 11,000 shares and ...

Thank you for standing by, and welcome to the Cochlear Limited Half Year 2025 Results Analyst and Media Briefing. All participants are in listen-only mode. There will be presentation, followed by a ...

MONTPELLIER, France & SYDNEY--(BUSINESS WIRE)--Regulatory News: Sensorion (Paris:ALSEN) (FR0012596468 – ALSEN) a pioneering clinical-stage biotechnology, which specializes in the development of novel ...